Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,524.80
(
0.83%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
105.66
(
-0.10%
)
Bitcoin
81,071.76
(
0.72%
)
News Focus
News Focus
Post# of 57909
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rusbrn

Send PM Follow Ignore
Followers 1
Posts 49
Boards Moderated 0
Alias Born 09/22/2005

rusbrn

Re: Aiming4 post# 8442

Friday, 08/24/2007 12:39:41 PM

Friday, August 24, 2007 12:39:41 PM

Post# of 57909
<Cortex aims to start a Phase IIb study in 2H07
with CX717 in ADHD, pending the acceptance of an IND including the request to test higher doses of CX717. This IND
has been submitted to the FDA�s Psychiatric Products Division and Cortex expects a decision in September 2007. >
Apparently some have not read post #8423
Russ.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today